©2025 Stanford Medicine
Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants?
Not Recruiting
Trial ID: NCT01944696
Purpose
Cycled (intermittent) phototherapy will be compared to continuous (uninterrupted) phototherapy in the treatment of hyperbilirubinemia (newborn jaundice) in extremely low birth weight newborns in a pilot randomized controlled trial.
Hypothesis: Cycled phototherapy (PT) will provide the same benefits as continuous phototherapy in extremely low birth weight (ELBW) infants without the risks that have been associated with continuous phototherapy.
Official Title
Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants?
Stanford Investigator(s)
Eligibility
Inclusion Criteria:
* birth weight 401-1000 grams
* age less than or equal to 24 hours
Exclusion Criteria:
* hemolytic disease
* major anomaly
* overt nonbacterial infection
Intervention(s):
other: phototherapy
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
David K Stevenson, MD
497-0735